期刊
BLOOD REVIEWS
卷 51, 期 -, 页码 -出版社
CHURCHILL LIVINGSTONE
DOI: 10.1016/j.blre.2021.100887
关键词
Multiple myeloma; High risk multiple myeloma; Measurable residual disease; Autologous stem cell transplantation; Allogeneic stem cell transplantation
类别
The optimal approach to the treatment of high risk multiple myeloma remains unclear due to variable definitions and limited studies dedicated to its treatment.
High risk multiple myeloma (HRMM) continues to portend worse outcomes despite the many advances in antimyeloma therapeutics. The optimal approach to treatment is not clearly defined on account of the variable definitions of HRMM and the paucity of studies dedicated to the treatment of HRMM. In this review, we use a case-based approach to review the definitions of HRMM, and evaluate the evidence for induction, stem cell transplantation, and post-transplant therapy approaches for HRMM.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据